• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

较高的血管生成素样蛋白3(ANGPTL3)、载脂蛋白C-III(apoC-III)和载脂蛋白B48(apoB48)血脂异常,以及较低的脂蛋白脂肪酶浓度,与肥胖青少年的内脏脂肪功能障碍有关。

Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity.

作者信息

Rodríguez-Mortera Reyna, Caccavello Russell, Garay-Sevilla Ma Eugenia, Gugliucci Alejandro

机构信息

Department of Medical Science, University of Guanajuato, Mexico; Glycation, Oxidation and Disease Laboratory, Dept. of Research, College of Osteopathic Medicine, Touro University California, United States.

Glycation, Oxidation and Disease Laboratory, Dept. of Research, College of Osteopathic Medicine, Touro University California, United States.

出版信息

Clin Chim Acta. 2020 Sep;508:61-68. doi: 10.1016/j.cca.2020.05.014. Epub 2020 May 11.

DOI:10.1016/j.cca.2020.05.014
PMID:32407781
Abstract

BACKGROUND

We hypothesized that adolescents with obesity have higher remnant B48 concentrations associated with lipoprotein lipase dysregulation.

METHODS

Cross-sectional study of 32 adolescents with obesity and 27 control subjects.

RESULTS

As compared to lean controls, obese participants showed 35% higher concentrations of apoB48: 3.60 (2.93-4.30) vs 2.65 (1.64-3.68) ng/ml; 28% of apoC-III: (72.7 (58.6-89.7) vs 56.9 (44.8-79.8 ug/ml and 17% ANGPTL 3: (72.2 ± 20.2 vs 61.2 ± 19.2 ng/ml). This was accompanied by a 33% reduction in LPL: 13.1 ± 5.1 vs 18.9 ± 4.7 ng/ml. Obese participants had 25% lower adiponectin 2.9 (1.9-3.8) vs 4.4 (3.2.-5.2) μg/ml; 260% higher leptin 25.7 (11.2-44.8) vs 9.3 (2.8-20.7) ng/ml and 83% higher Il-6: 2.2 (1.3-5.4) vs 1.2 (0.8-1.4) pg/ml. ApoC-III and ANGPTL3 correlated positively with VAI; ANGPTL3 negatively with HDL-C; LDL size and VLDL-C. ApoB48 correlated negatively with LDL-C.

CONCLUSIONS

Adolescents with obesity show higher ANGPTL3 compounded with increased apoC-III associated with increased CR and lower LPL mass. This is associated with inflammation and visceral fat. The significance of these findings resides in that they shed light on a mechanism for TRL dyslipidemia in adolescents: increased LPL inhibition impairs VLDL and chylomicron catabolism leading to atherogenic remnants.

摘要

背景

我们推测肥胖青少年的残余B48浓度较高,这与脂蛋白脂肪酶失调有关。

方法

对32名肥胖青少年和27名对照受试者进行横断面研究。

结果

与瘦对照组相比,肥胖参与者的载脂蛋白B48浓度高35%:分别为3.60(2.93 - 4.30)与2.65(1.64 - 3.68)ng/ml;载脂蛋白C-III高28%:分别为72.7(58.6 - 89.7)与56.9(44.8 - 79.8)μg/ml,血管生成素样蛋白3(ANGPTL 3)高17%:分别为72.2 ± 20.2与61.2 ± 19.2 ng/ml。同时脂蛋白脂肪酶(LPL)降低了33%:分别为13.1 ± 5.1与18.9 ± 4.7 ng/ml。肥胖参与者的脂联素降低25%:分别为2.9(1.9 - 3.8)与4.4(3.2 - 5.2)μg/ml;瘦素高260%:分别为25.7(11.2 - 44.8)与9.3(2.8 - 20.7)ng/ml,白细胞介素-6(Il-6)高83%:分别为2.2(1.3 - 5.4)与1.2(0.8 - 1.4)pg/ml。载脂蛋白C-III和ANGPTL3与内脏脂肪指数(VAI)呈正相关;ANGPTL3与高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白大小和极低密度脂蛋白胆固醇(VLDL-C)呈负相关。载脂蛋白B48与低密度脂蛋白胆固醇(LDL-C)呈负相关。

结论

肥胖青少年的ANGPTL3升高,同时载脂蛋白C-III增加,伴有C反应蛋白(CR)升高和LPL质量降低。这与炎症和内脏脂肪有关。这些发现的意义在于揭示了青少年甘油三酯丰富的脂蛋白(TRL)血脂异常的机制:LPL抑制增加损害了极低密度脂蛋白和乳糜微粒的分解代谢,导致致动脉粥样硬化的残余物。

相似文献

1
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity.较高的血管生成素样蛋白3(ANGPTL3)、载脂蛋白C-III(apoC-III)和载脂蛋白B48(apoB48)血脂异常,以及较低的脂蛋白脂肪酶浓度,与肥胖青少年的内脏脂肪功能障碍有关。
Clin Chim Acta. 2020 Sep;508:61-68. doi: 10.1016/j.cca.2020.05.014. Epub 2020 May 11.
2
Lean adolescents with insulin resistance display higher angiopoietin like protein 3, ApoC-III and chylomicron remnant dyslipidemia.瘦素抵抗的青少年表现出更高的血管生成素样蛋白 3、载脂蛋白 C-III 和乳糜微粒残粒血脂异常。
Clin Chim Acta. 2022 Feb 1;526:43-48. doi: 10.1016/j.cca.2021.12.016. Epub 2021 Dec 29.
3
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.富含甘油三酯的脂蛋白、载脂蛋白C-III、血管生成素样蛋白3与老年人心血管事件:社区动脉粥样硬化风险(ARIC)研究
Eur J Prev Cardiol. 2022 Mar 11;29(2):e53-e64. doi: 10.1093/eurjpc/zwaa152.
4
Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.血清血管生成素样蛋白 3 和 8 与非糖尿病成人致动脉粥样硬化脂质生物标志物的关系取决于性别和肥胖。
Nutrients. 2021 Nov 30;13(12):4339. doi: 10.3390/nu13124339.
5
Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.在绝经后超重和肥胖女性中,富含甘油三酯的脂蛋白与载脂蛋白C-I的富集与其血浆清除延迟呈正相关,且独立于其他可转移载脂蛋白。
J Nutr. 2017 May;147(5):754-762. doi: 10.3945/jn.116.242750. Epub 2017 Mar 29.
6
Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.血浆血管生成素样蛋白 3(ANGPTL3)浓度与尿毒症血脂异常有关。
Atherosclerosis. 2009 Dec;207(2):579-84. doi: 10.1016/j.atherosclerosis.2009.05.023. Epub 2009 May 27.
7
Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.极低密度脂蛋白/脂病毒颗粒通过载脂蛋白 C-III 逆转脂蛋白脂酶介导的丙型肝炎病毒感染抑制作用。
Gut. 2013 Aug;62(8):1193-203. doi: 10.1136/gutjnl-2011-301798. Epub 2012 Jun 11.
8
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.内脏肥胖中载脂蛋白B-100的动力学:与血浆载脂蛋白C-III浓度的关联
Metabolism. 2002 Aug;51(8):1041-6. doi: 10.1053/meta.2002.33339.
9
WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.白色脂肪组织载脂蛋白C-I的分泌:在肥胖受试者体内及离体白色脂肪组织中对乳糜微粒清除延迟的作用。
J Lipid Res. 2016 Jun;57(6):1074-85. doi: 10.1194/jlr.P064170. Epub 2016 Apr 3.
10
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?ANGPTL3 和 ApoC-III 抑制剂治疗高甘油三酯血症:因马而异?
Curr Opin Lipidol. 2024 Jun 1;35(3):101-109. doi: 10.1097/MOL.0000000000000920. Epub 2024 Feb 19.

引用本文的文献

1
Exploring Glyoxalase Strategies for Managing Sugar-Induced Chronic Diseases.探索乙二醛酶策略以应对糖诱导的慢性疾病
Life (Basel). 2025 May 16;15(5):794. doi: 10.3390/life15050794.
2
An overview of persistent chylomicronemia: much more than meets the eye.持续性乳糜微粒血症概述:远不止所见那么简单。
Curr Opin Endocrinol Diabetes Obes. 2025 Apr 1;32(2):75-88. doi: 10.1097/MED.0000000000000903. Epub 2025 Feb 10.
3
The chylomicron saga: time to focus on postprandial metabolism.乳糜微粒传奇:是时候关注餐后代谢了。
Front Endocrinol (Lausanne). 2024 Jan 18;14:1322869. doi: 10.3389/fendo.2023.1322869. eCollection 2023.
4
Interplay of Postprandial Triglyceride-Rich Lipoprotein Composition and Adipokines in Obese Adolescents.肥胖青少年餐后富含甘油三酯的脂蛋白组成与脂肪因子的相互作用。
Int J Mol Sci. 2024 Jan 16;25(2):1112. doi: 10.3390/ijms25021112.
5
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.探索载脂蛋白 C-III:病理生理学和药理学相关性。
Cardiovasc Res. 2024 Feb 17;119(18):2843-2857. doi: 10.1093/cvr/cvad177.
6
Sugar and Dyslipidemia: A Double-Hit, Perfect Storm.糖与血脂异常:双重打击,完美风暴。
J Clin Med. 2023 Aug 31;12(17):5660. doi: 10.3390/jcm12175660.
7
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux.富含甘油三酯的脂蛋白代谢:其通量的关键调节因子
J Clin Med. 2023 Jun 29;12(13):4399. doi: 10.3390/jcm12134399.
8
Obesity and Dyslipidemia: A Review of Current Evidence.肥胖与血脂异常:当前证据综述。
Curr Obes Rep. 2023 Sep;12(3):207-222. doi: 10.1007/s13679-023-00518-z. Epub 2023 Jul 6.
9
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.动脉粥样硬化中的甘油三酯及富含甘油三酯的脂蛋白
Front Mol Biosci. 2022 May 25;9:909151. doi: 10.3389/fmolb.2022.909151. eCollection 2022.
10
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).越来越多的证据表明极低密度脂蛋白(VLDL)具有病理性作用。
Int J Mol Sci. 2022 Apr 13;23(8):4300. doi: 10.3390/ijms23084300.